CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.390
-0.020 (-4.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.390
-0.000 (-0.03%)
After-hours: Apr 28, 2026, 6:39 PM EDT
CollPlant Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 2.37 | 0.52 | 10.96 | 0.3 | 15.64 | |
| Revenue Growth (YoY) | 360.39% | -95.30% | 3565.22% | -98.09% | 154.86% | |
| Cost of Revenue | 0.84 | 1.63 | 1.99 | 0.4 | 2.01 | |
| Gross Profit | 1.54 | -1.11 | 8.97 | -0.1 | 13.64 | |
| Selling, General & Admin | 4.83 | 5.63 | 6 | 6.74 | 5.94 | |
| Research & Development | 8.19 | 10.52 | 10.48 | 10.26 | 7.63 | |
| Operating Expenses | 13.02 | 16.14 | 16.48 | 17 | 13.57 | |
| Operating Income | -11.48 | -17.25 | -7.51 | -17.1 | 0.07 | |
| Interest Expense | - | - | - | -0.02 | -0.01 | |
| Interest & Investment Income | 0.38 | 0.74 | 0.79 | 0.32 | 0.22 | |
| Currency Exchange Gain (Loss) | -0.37 | -0.08 | -0.29 | -0.12 | -0.04 | |
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.01 | -0.01 | -0 | |
| Pretax Income | -11.49 | -16.61 | -7.02 | -16.93 | 0.24 | |
| Net Income | -11.49 | -16.61 | -7.02 | -16.93 | 0.24 | |
| Net Income to Common | -11.49 | -16.61 | -7.02 | -16.93 | 0.24 | |
| Shares Outstanding (Basic) | 12 | 11 | 11 | 11 | 10 | |
| Shares Outstanding (Diluted) | 12 | 11 | 11 | 11 | 12 | |
| Shares Change (YoY) | 6.54% | 0.57% | 3.23% | -7.80% | 73.76% | |
| EPS (Basic) | -0.94 | -1.45 | -0.62 | -1.53 | 0.02 | |
| EPS (Diluted) | -0.94 | -1.45 | -0.62 | -1.53 | 0.02 | |
| Free Cash Flow | -9.45 | -14.58 | -3.72 | -14.97 | 1.07 | |
| Free Cash Flow Per Share | -0.77 | -1.27 | -0.33 | -1.36 | 0.09 | |
| Gross Margin | 64.78% | -215.53% | 81.83% | -33.78% | 87.18% | |
| Operating Margin | -484.31% | -3349.71% | -68.55% | -5718.06% | 0.42% | |
| Profit Margin | -484.56% | -3225.05% | -64.05% | -5660.53% | 1.52% | |
| Free Cash Flow Margin | -398.44% | -2830.29% | -33.92% | -5007.36% | 6.86% | |
| EBITDA | -10.57 | -16.21 | -6.41 | -16.02 | 0.84 | |
| EBITDA Margin | - | - | -58.49% | - | 5.36% | |
| D&A For EBITDA | 0.91 | 1.04 | 1.1 | 1.08 | 0.77 | |
| EBIT | -11.48 | -17.25 | -7.51 | -17.1 | 0.07 | |
| EBIT Margin | - | - | -68.55% | - | 0.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.